GlassScriptPhysician profile
Tyson C Garfield
NPI 1821417395
$952.97
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.44 · 2021: $119 · 2022: $354 · 2023: $382 · 2024: $84.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $177.64 | 2022-2023 | Ingrezza, Ongentys |
| Mylan Specialty L.P. | $173.46 | 2022-2023 | Yupelri |
| Otsuka America Pharmaceutical, INC. | $104.12 | 2023-2024 | Rexulti, Nuedexta |
| Teva Pharmaceuticals USA, INC. | $99.97 | 2021-2023 | Austedo Xr |
| Biogen, INC. | $76.05 | 2021 | |
| Argenx US, INC. | $53.79 | 2023 | Vyvgart |
| Eisai INC. | $49.13 | 2024 | |
| Avanir Pharmaceuticals, INC. | $38.86 | 2022 | |
| Glaxosmithkline, LLC. | $35.80 | 2022-2023 | Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.71 | 2022-2023 | Ofev |
| Novartis Pharmaceuticals Corporation | $25.04 | 2021-2022 | |
| Ucb, INC. | $18.60 | 2021 | |
| Acadia Pharmaceuticals INC | $16.46 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.87 | 2023 | Ultomiris |
| Ultragenyx Pharmaceutical INC. | $13.62 | 2024 | Crysvita |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $13.44 | 2020 | |
| Novo Nordisk INC | $13.41 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyson Garfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.